BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28799818)

  • 41. Th1high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC.
    Huang J; Shen F; Huang H; Ling C; Zhang G
    Oncotarget; 2017 Feb; 8(8):13116-13125. PubMed ID: 28061450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pragmatic approach to the diagnosis of nodal micrometastases in early stage non-small cell lung cancer.
    Herpel E; Muley T; Schneider T; Palm E; Kieslich de Hol D; Warth A; Meister M; Storz K; Schnabel PA; Schirmacher P; Dienemann H; Hoffmann H
    J Thorac Oncol; 2010 Aug; 5(8):1206-12. PubMed ID: 20581709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up.
    Toomey D; Smyth G; Condron C; Kelly J; Byrne AM; Kay E; Conroy RM; Broe P; Bouchier-Hayes D
    Int J Cancer; 2003 Jan; 103(3):408-12. PubMed ID: 12471625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcoidal reactions in regional lymph nodes of patients with non-small cell lung cancer: incidence and implications for minimally invasive staging with endobronchial ultrasound.
    Steinfort DP; Irving LB
    Lung Cancer; 2009 Dec; 66(3):305-8. PubMed ID: 19329219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer.
    Ito M; Minamiya Y; Kawai H; Saito S; Saito H; Imai K; Ogawa J
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):753-8. PubMed ID: 16153924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer.
    Lafuente-Sanchis A; Zúñiga Á; Estors M; Martínez-Hernández NJ; Cremades A; Cuenca M; Galbis JM
    Clin Lung Cancer; 2017 Mar; 18(2):e109-e116. PubMed ID: 27816393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
    Chae YK; Pan A; Davis AA; Raparia K; Mohindra NA; Matsangou M; Giles FJ
    Clin Lung Cancer; 2016 Sep; 17(5):350-361. PubMed ID: 27137346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
    Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
    J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung Cancer.
    Kato Y; Kashima J; Watanabe K; Yomota M; Zenke Y; Okuma Y; Hosomi Y; Gemma A; Seike M; Okamura T
    Anticancer Res; 2018 Feb; 38(2):1077-1083. PubMed ID: 29374744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.
    Shen C; Liu C; Zhang Z; Ping Y; Shao J; Tian Y; Yu W; Qin G; Liu S; Wang L; Zhang Y
    Front Immunol; 2021; 12():680055. PubMed ID: 34194433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity.
    Maeda J; Inoue M; Okumura M; Ohta M; Minami M; Shiono H; Shintani Y; Matsuda H; Matsuura N
    Lung Cancer; 2006 May; 52(2):235-40. PubMed ID: 16510209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PD-L1 expression in small cell neuroendocrine carcinomas.
    Schultheis AM; Scheel AH; Ozretić L; George J; Thomas RK; Hagemann T; Zander T; Wolf J; Buettner R
    Eur J Cancer; 2015 Feb; 51(3):421-6. PubMed ID: 25582496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
    Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequent down-regulation of pim-1 mRNA expression in non-small cell lung cancer is associated with lymph node metastases.
    Warnecke-Eberz U; Bollschweiler E; Drebber U; Pohl A; Baldus SE; Hoelscher AH; Metzger R
    Oncol Rep; 2008 Sep; 20(3):619-24. PubMed ID: 18695914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
    Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
    Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro.
    Koizumi K; Kozawa Y; Ohashi Y; Nakamura ES; Aozuka Y; Sakurai H; Ichiki K; Doki Y; Misaki T; Saiki I
    Oncol Rep; 2007 Jun; 17(6):1511-6. PubMed ID: 17487412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Detection of micrometastasis in mediastinal lymph nodes in operable non-small cell lung cancers].
    Yang HX; Wu YL; Ding JA; Jiang GN; Zhou X; Chen C; Gao W; Chen G
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):368-70. PubMed ID: 17045003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.